Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Oncol. 1997 Mar;9(2):189-204.

Adjuvant therapy for melanoma.

Author information

1
Taubman Center, Ann Arbor, MI 48109-0331, USA.

Abstract

The search for effective adjuvant therapy for melanoma has resulted in the testing of a remarkably broad spectrum of therapeutic agents. Until recently, there was little evidence to suggest a benefit for any adjuvant therapy. The demonstration of activity for adjuvant high-dose interferon alfa in a cooperative group trial resulted in Food and Drug Administration approval and has dramatically changed the melanoma landscape. This article reviews all the randomized adjuvant trials conducted to date in melanoma, discusses pertinent studies still in progress or awaiting analysis, and offers recommendations for the adjuvant treatment of melanoma patients rendered clinically disease-free by surgery.

Comment in

PMID:
9161800
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Loading ...
    Support Center